These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

142 related articles for article (PubMed ID: 37148271)

  • 1. Mitigating a Bioactivation Liability with an Azetidine-Based Inhibitor of Diacylglycerol Acyltransferase 2 (DGAT2) En Route to the Discovery of the Clinical Candidate Ervogastat.
    Sharma R; Dowling MS; Futatsugi K; Kalgutkar AS
    Chem Res Toxicol; 2023 Jun; 36(6):934-946. PubMed ID: 37148271
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Discovery of Ervogastat (PF-06865571): A Potent and Selective Inhibitor of Diacylglycerol Acyltransferase 2 for the Treatment of Non-alcoholic Steatohepatitis.
    Futatsugi K; Cabral S; Kung DW; Huard K; Lee E; Boehm M; Bauman J; Clark RW; Coffey SB; Crowley C; Dechert-Schmitt AM; Dowling MS; Dullea R; Gosset JR; Kalgutkar AS; Kou K; Li Q; Lian Y; Loria PM; Londregan AT; Niosi M; Orozco C; Pettersen JC; Pfefferkorn JA; Polivkova J; Ross TT; Sharma R; Stock IA; Tesz G; Wisniewska H; Goodwin B; Price DA
    J Med Chem; 2022 Nov; 65(22):15000-15013. PubMed ID: 36322383
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Inhibition of Diacylglycerol Acyltransferase 2 Versus Diacylglycerol Acyltransferase 1: Potential Therapeutic Implications of Pharmacology.
    Amin NB; Saxena AR; Somayaji V; Dullea R
    Clin Ther; 2023 Jan; 45(1):55-70. PubMed ID: 36690550
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Bioactivation of phencyclidine in rat and human liver microsomes and recombinant P450 2B enzymes: evidence for the formation of a novel quinone methide intermediate.
    Driscoll JP; Kornecki K; Wolkowski JP; Chupak L; Kalgutkar AS; O'Donnell JP
    Chem Res Toxicol; 2007 Oct; 20(10):1488-97. PubMed ID: 17892269
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Strategies toward optimization of the metabolism of a series of serotonin-4 partial agonists: investigation of azetidines as piperidine isosteres.
    Obach RS; LaChapelle EA; Brodney MA; Vanase-Frawley M; Kauffman GW; Sawant-Basak A
    Xenobiotica; 2016 Dec; 46(12):1112-1121. PubMed ID: 26947511
    [TBL] [Abstract][Full Text] [Related]  

  • 6. NADPH-dependent covalent binding of [3H]paroxetine to human liver microsomes and S-9 fractions: identification of an electrophilic quinone metabolite of paroxetine.
    Zhao SX; Dalvie DK; Kelly JM; Soglia JR; Frederick KS; Smith EB; Obach RS; Kalgutkar AS
    Chem Res Toxicol; 2007 Nov; 20(11):1649-57. PubMed ID: 17907785
    [TBL] [Abstract][Full Text] [Related]  

  • 7. A rational chemical intervention strategy to circumvent bioactivation liabilities associated with a nonpeptidyl thrombopoietin receptor agonist containing a 2-amino-4-arylthiazole motif.
    Kalgutkar AS; Driscoll J; Zhao SX; Walker GS; Shepard RM; Soglia JR; Atherton J; Yu L; Mutlib AE; Munchhof MJ; Reiter LA; Jones CS; Doty JL; Trevena KA; Shaffer CL; Ripp SL
    Chem Res Toxicol; 2007 Dec; 20(12):1954-65. PubMed ID: 17935300
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Identification of multiple glutathione conjugates of 8-amino- 2-methyl-4-phenyl-1,2,3,4-tetrahydroisoquinoline maleate (nomifensine) in liver microsomes and hepatocyte preparations: evidence of the bioactivation of nomifensine.
    Yu J; Mathisen DE; Burdette D; Brown DG; Becker C; Aharony D
    Drug Metab Dispos; 2010 Jan; 38(1):46-60. PubMed ID: 19812352
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Metabolic activation and major protein target of a 1-benzyl-3-carboxyazetidine sphingosine-1-phosphate-1 receptor agonist.
    Aloysius H; Tong VW; Yabut J; Bradley SA; Shang J; Zou Y; Tschirret-Guth RA
    Chem Res Toxicol; 2012 Jul; 25(7):1412-22. PubMed ID: 22765480
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Mechanistic studies on the metabolic scission of thiazolidinedione derivatives to acyclic thiols.
    Reddy VB; Karanam BV; Gruber WL; Wallace MA; Vincent SH; Franklin RB; Baillie TA
    Chem Res Toxicol; 2005 May; 18(5):880-8. PubMed ID: 15892582
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Evidence for the bioactivation of zomepirac and tolmetin by an oxidative pathway: identification of glutathione adducts in vitro in human liver microsomes and in vivo in rats.
    Chen Q; Doss GA; Tung EC; Liu W; Tang YS; Braun MP; Didolkar V; Strauss JR; Wang RW; Stearns RA; Evans DC; Baillie TA; Tang W
    Drug Metab Dispos; 2006 Jan; 34(1):145-51. PubMed ID: 16251255
    [TBL] [Abstract][Full Text] [Related]  

  • 12. In vitro metabolism of oxymetazoline: evidence for bioactivation to a reactive metabolite.
    Mahajan MK; Uttamsingh V; Daniels JS; Gan LS; LeDuc BW; Williams DA
    Drug Metab Dispos; 2011 Apr; 39(4):693-702. PubMed ID: 21177487
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Novel bioactivation mechanism of reactive metabolite formation from phenyl methyl-isoxazoles.
    Bylund J; Macsari I; Besidski Y; Olofsson S; Petersson C; Arvidsson PI; Bueters T
    Drug Metab Dispos; 2012 Nov; 40(11):2185-91. PubMed ID: 22908203
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Structural characterization of novel adenine dinucleotide phosphate conjugates of imatinib in incubations with rat and human liver microsomes.
    Ma S; Subramanian R; Xu Y; Schrag M; Shou M
    Drug Metab Dispos; 2008 Dec; 36(12):2414-8. PubMed ID: 18799804
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Bioactivation of isothiazoles: minimizing the risk of potential toxicity in drug discovery.
    Teffera Y; Choquette D; Liu J; Colletti AE; Hollis LS; Lin MH; Zhao Z
    Chem Res Toxicol; 2010 Nov; 23(11):1743-52. PubMed ID: 20825217
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Metabolism and bioactivation of 3-methylindole by human liver microsomes.
    Yan Z; Easterwood LM; Maher N; Torres R; Huebert N; Yost GS
    Chem Res Toxicol; 2007 Jan; 20(1):140-8. PubMed ID: 17226936
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Metabolism of the chemoprotective agent diallyl sulfide to glutathione conjugates in rats.
    Jin L; Baillie TA
    Chem Res Toxicol; 1997 Mar; 10(3):318-27. PubMed ID: 9084912
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Cytochrome P450 3A4-mediated oxidative conversion of a cyano to an amide group in the metabolism of pinacidil.
    Zhang Z; Li Y; Stearns RA; Ortiz De Montellano PR; Baillie TA; Tang W
    Biochemistry; 2002 Feb; 41(8):2712-8. PubMed ID: 11851418
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Metabolic activation of a pyrazinone-containing thrombin inhibitor. Evidence for novel biotransformation involving pyrazinone ring oxidation, rearrangement, and covalent binding to proteins.
    Singh R; Silva Elipe MV; Pearson PG; Arison BH; Wong BK; White R; Yu X; Burgey CS; Lin JH; Baillie TA
    Chem Res Toxicol; 2003 Feb; 16(2):198-207. PubMed ID: 12588191
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Extrahepatic in vitro metabolism of peptides; comparison of human kidney and intestinal S9 fraction, human plasma and proximal tubule cells, using cyclosporine A, leuprorelin, and cetrorelix as model compounds.
    Jyrkäs J; Lassila T; Tolonen A
    J Pharm Biomed Anal; 2023 Feb; 225():115219. PubMed ID: 36630767
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.